Choices in vaccine trial design in epidemics of emerging infections


In outbreaks of emerging infectious diseases for which no proven efficacious vaccines exist but investigational vaccines have been developed, it is important both to rapidly test the investigational vaccines and, if effective, to deploy them.

Content Information

Content Author: 
Rebecca Kahn, Annette Rid
Content Source: 
PLOS Medicine
Content Type: 
News